SCII and GVBP stem cells bring big gains today- sourced PicksThatMove.com

Sept. 11, 2009 - PRLog -- Calgary, AB - PicksThatMove.com opines promising trading opportunities with likely potential for gain. The companies we follow have favourable revenue models for business development at upward cycles.  To view more of our profiled stocks, please visit us at PicksThatMove.com

The hot stock information includes: SCII, GVBP

Stem Cell Therapy International Inc,  refers patients to stem cell treatment facilities and sells the stem cell biological solutions to treatment centers.  They announced yesterday they have a litigation settlement with Histostem requiring the two companies to merge.  Their stock has jumped up 41.5% today trading at $0.75 with more than 777k shares moving by the afternoon.

Genova Biotherapeutics Inc,  is a bioscience company developing therapeutic proteins for use in life-threatening cancers.  Today they announced a new stem cell identification technology that could be used in the cure for breast cancer.  This news has brought healthy gain with shares trading up 43% at $.319 with an amazing volume of more than 59 million by mid-afternoon trading.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock.